Mattifying Agents Market

Mattifying Agents Market Size, Market Forecast and Outlook By FMI

In 2025, the mattifying agents market was valued at USD 13.4 billion. Demand for mattifying agents is estimated to grow to USD 14.2 billion in 2026 and USD 24.7 billion by 2036. FMI projects a CAGR of 5.7% during the forecast period.

A clear “competence gap” has emerged in the current market, with operational excellence now weighing as heavily as product innovation. The broad-based boost seen in the post‑pandemic phase has faded, and companies with generic, non‑specialized skincare portfolios are facing heightened pressure due to insufficient dermatological expertise. For instance, execution challenges in the USA commercial environment led to a notable 4.5% organic decline in the Skin Health & Beauty segment of Kenvue in early 2024, demonstrating that mass-market distribution is no longer a safety net against consumer churn [1]. This contraction forces a strategic realignment towards precision skincare, where growth is increasingly captured by brands that can navigate the complex regulatory landscape of "active" ingredients.

Summary of Mattifying Agents Market

• Mattifying Agents Market Definition
  • The industry covers the supply of functional ingredients that manage sebum production and skin reflectivity in cosmetic formulations.
• Demand Drivers in the Market
  • Transition from aesthetic masking (powders) to therapeutic treatment (actives) of oily skin.
  • "Medicalization" of beauty standards driving consumers toward clinical claims.
  • Regulatory pressure forcing the replacement of talc and silica with cleaner alternatives.
• Key Segments Analyzed in the FMI Report
  • Form: Mattifying Creams dominate (34.7%) due to the rise of hybrid moisturizing skincare products.
  • Skin Type: Acne-Prone Skin is the fastest-growing segment, fueled by adult acne prevalence.
  • Region: Asia Pacific leads in volume growth, while Europe leads in premium active innovation.
• Analyst Opinion at FMI
  • Ronak Shah, Associate Vice President for Consumer Product, Travel and Tourism at Future Market Insights, opines, "The era of 'spray and pray' formulation is over. The new FDA MoCRA mandates and China's efficacy thresholds are creating a regulatory moat that protects science-backed players while squeezing out 'clean-washing' indie brands. Suppliers who can offer clinical data packages alongside their ingredients, proving actual sebum reduction rather than just oil absorption, will command the pricing power in this new cycle."
• Strategic Implications/Executive Takeaways
  • Prioritize R&D in bio-fermentation to replace finite mineral extractives.
  • Localize manufacturing in India to capture the high-volume tropical market.
  • Develop ingredient dossiers that satisfy dual regulatory standards (US & China) to enable global SKU streamlining.
• Methodology
  • Validated through first-hand corporate production and capacity data.
  • Zero reliance on speculative third-party market research reports.
  • Based on verifiable industrial benchmarks and verified sources.

Vincent Warnery, CEO of Beiersdorf AG, highlighted the commercial superiority of this focused approach during the Full Year 2024 results: "In the first half of 2025, Beiersdorf delivered a solid performance. However, the global skin care market experienced a slower growth than expected, particularly in the second quarter and into July 2025. This is why we adjusted our guidance for the Group and the Consumer Business Segment for the full year of 2025. Nevertheless, we expect to accelerate growth in the second half driven by our strong innovation pipeline.” [2] This statement serves as a bellwether for the industry: the most lucrative opportunities now lie in "medicalized" skincare, compelling ingredient suppliers to pivot their R&D from physical oil absorbers to clinical-grade metabolic regulators that can substantiate "Derma" claims.

China is expected to see steady expansion (7.6% CAGR), supported by a strong shift toward advanced cosmetic innovation. India continues to gain momentum (7.1% CAGR) as its beauty and personal care market modernizes and diversifies. Germany maintains consistent performance (6.5% CAGR) driven by its established dermocosmetic ecosystem. Brazil shows healthy growth (5.9% CAGR) as its mass‑market beauty segment strengthens. The United States remains a sizable and stable contributor (5.4% CAGR), reflecting its mature but evolving skincare landscape.

Mattifying Agents Market Definition

The mattifying agents industry comprises the global production and trade of functional ingredients, ranging from mineral microspheres to bio-fermented actives, designed to reduce skin shine, absorb excess sebum, and refine pore texture. These agents are the functional core of leave-on and rinse-off formulations in the personal care sector.

Mattifying Agents Market Inclusions

This report analyzes the consumption of sebum-control ingredients across the entire beauty value chain. It includes synthetic polymers, natural starches, clays, and advanced biotech molecules used in facial care products, cosmetic primers, and sunscreens, tracking their application in both mass-market retail and premium dermocosmetic channels.

Mattifying Agents Market Exclusions

The scope strictly excludes prescription-only dermatological drugs (such as isotretinoin or heavy antibiotics) and generic pharmaceutical excipients that lack specific sebum-regulating claims. It also omits raw commodity minerals sold for non-cosmetic industrial applications, focusing solely on high-purity grades intended for personal care formulations.

Mattifying Agents Market Research Methodology

• Primary Research: In-depth interviews were conducted with R&D directors at major ingredient houses, procurement heads at multinational beauty brands, and regulatory consultants specializing in MoCRA and NMPA compliance.
• Desk Research: Analysis included corporate earnings calls, patent filings for sebum-control technologies, and regulatory policy documents to reconstruct market dynamics.
• Market-Sizing and Forecasting: A bottom-up model was utilized, aggregating ingredient volume demand from finished product sales in the oily skin control products sector and validating against supply-side production capacities.
• Data Validation and Update Cycle: All data points underwent rigorous cross-verification against trade codes and public financial disclosures to ensure accuracy and eliminate speculative estimates.

Segmental Analysis

Mattifying Agents Market Analysis by Form

Mattifying Creams are estimated to hold a dominant value share of 34.7% in 2026, driven by the structural shift from single-function oil absorbers to multi-functional barrier supports. The modern formulation architecture has evolved; consumers now reject the "dry down" effect of traditional silica-heavy products in favor of barrier-repairing emulsions. This trend is substantiated by the performance of clinically-positioned portfolios; for instance, L'Oréal Group's Active Cosmetics division reported sales of €43.48 billion with +5.6% growth in 2024, confirming that consumers are migrating toward cream-based formats that deliver "health" alongside aesthetics [3]. Conversely, Mattifying Powders face a relative share erosion, retaining relevance primarily in the anti-caking makeup products segment for "on-the-go" touch-ups rather than as a primary treatment step.

• Mattifying Creams: Dominance is reinforced by the "skinification" of makeup, where consumers demand active-loaded moisturizers that treat while they cover [3].
• Mattifying Gels: Gaining traction in high-humidity zones due to residue-free application, a critical preference for the 46.3% of the market dominated by oily skin types.
• Mattifying Powders: Sustaining usage in color cosmetics but losing ground in daily skincare routines as talc-free "clean" formulations struggle to match the performance of legacy minerals.

Mattifying Agents Market Analysis by Skin Type

The Oily Skin segment accounts for 46.3% of global volume, serving as the foundational revenue base, yet the Acne-Prone segment is witnessing the most aggressive R&D investment. This divergence is fueled by the "medicalization" of the category, where adult acne is treated as a chronic dermatological condition rather than a temporary cosmetic issue. Investment capital is flowing rapidly into this space; for example, Foxtale, an Indian D2C brand, raised USD 30 million in Series B funding in early 2025 specifically to expand its range of science-backed formulations for acne and pigmentation, proving that the market rewards targeted efficacy over broad-spectrum claims [4]. Consequently, brands are reformulating astringents to include microbiome-friendly claims, moving away from alcohol-based stripping to biological regulation.

• Oily Skin: 46.3% share; anchored by the growing male grooming sector which favors "invisible" mattification without the cosmetic finish of powders.
• Acne-Prone Skin: The primary value driver for biotech actives, supported by the emergence of precision brands that treat sebum dysbiosis [4].
• Sensitive Skin: Demanding "free-from" formulations, pushing the adoption of soothing skin care products that use fermented calmers instead of harsh drying agents.

Mattifying Agents Market Drivers, Restraints, and Opportunities

The enforcement of rigorous safety legislation is the single most transformative driver in the current market landscape. In the United States, the FDA's implementation of the Modernization of Cosmetics Regulation Act (MoCRA) now mandates comprehensive facility registration and product listing, effectively raising the barrier to entry for non-compliant "white label" suppliers [5]. This regulatory "cleansing" favors established, transparent manufacturers who can guarantee traceability, thereby consolidating market share.

Conversely, the market is restrained by macroeconomic fragility in traditional luxury strongholds. Estée Lauder Companies reported a 3% organic decline in its global business, primarily attributed to a slowdown in prestige beauty in mainland China, illustrating that high-end positioning is no longer a shield against volume contraction [6].

Despite these headwinds, significant opportunity lies in the "biotech pivot." As consumers reject synthetic polymers, brands are turning to bio-fermented ingredients that offer sustainable efficacy. Companies like Debut are capitalizing on this, having raised USD 86.2 million to scale their proprietary biotech ingredient manufacturing, signaling a lucrative future for suppliers who can replace mined minerals with lab-grown molecules [7].

• Regulatory Moat: MoCRA compliance is now a prerequisite for doing business, filtering out low-quality competition and favoring large-scale, compliant CDMOs [5].
• Luxury Volatility: Dependence on prestige consumption in China remains a key vulnerability, as evidenced by Estée Lauder's struggle with regional "travel retail" destocking [6].
• Biotech Integration: Developing bio-based gloss control agents offers a pathway to bypass raw material price fluctuations and meet clean beauty standards [7].

Regional Analysis

Based on the regional analysis, urea formaldehyde market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa across 40+ countries. The full report also offers market attractiveness analysis based on regional trends.

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research

Asia Pacific Mattifying Agents Market Analysis

Asia Pacific is pivoting from a passive consumption hub to a regulatory-driven innovation engine. The region is characterized by a "dual-speed" market: China is focusing on high-tech regulatory integration, while India is scaling through mass adoption of dermocosmetics in tropical conditions. The strategic imperative here is "localization of efficacy", global formulations are being re-engineered to withstand high humidity levels while meeting stricter local safety standards.

• China: Market expansion is anticipated to clock a 7.6% CAGR through 2036. The landscape is being reshaped by the National Medical Products Administration (NMPA), which issued "Opinions on Deepening Reform" in late 2025; these reforms allow for the exemption of foreign marketing authorization documents for products "first launched" in China, creating a massive incentive for global brands to debut their most advanced oil-control IP in Shanghai [8].
• India: Sales volume is expected to accelerate at a 7.1% CAGR through 2036. Growth is underpinned by a surging demand for accessible dermocosmetics, a trend validated by the rapid expansion of domestic players like Foxtale who are democratizing access to high-performance active ingredients [4].

FMI’s report includes a detailed analysis of growth in the Asia Pacific region, along with a country-wise assessment that includes China, India, Japan, South Korea, and Indonesia. Readers can also find regional trends, regulations, and market growth based on different segments and countries in Asia Pacific.

North America Mattifying Agents Market Analysis

North America is currently experiencing a "Regulatory Cleansing" phase that is consolidating market share among compliant, science-backed players. The focus has shifted entirely from "clean beauty" marketing to "clinical substantiation," driven by federal mandates that penalize ambiguity. This environment is forcing a capital pivot toward biotechnology, where companies are developing microbiome-modulating ingredients to replace traditional chemical drying agents.

• United States: The market is forecast to advance at a 5.4% CAGR through 2036. The primary structural driver is the FDA’s enforcement of the Modernization of Cosmetics Regulation Act (MoCRA), which now requires facility registration and rigorous safety substantiation, thereby squeezing out low-quality "white label" mattifying products and favoring established manufacturers with traceable supply chains [5].

FMI’s report includes a detailed analysis of growth in the North America region, along with a country-wise assessment that includes the United States, Canada, and Mexico. Readers can also find regional trends, regulations, and market growth based on different segments and countries in North America.

Europe Mattifying Agents Market Analysis

Europe remains the global R&D command center, where value creation is linked to "patented precision" rather than volume. The region's growth is sustained by the export of "trust," as European dermocosmetic standards become the global baseline for efficacy. The market here is highly responsive to ingredient innovation; consumers are willing to pay premiums for proprietary molecules that offer proven biological results over generic commodity ingredients.

• Germany: The sector is projected to progress at a 6.5% CAGR through 2036. The market is anchored by domestic giants like Beiersdorf, whose "Derma" business unit grew by 10.6% in 2024, validating the region's strong appetite for scientifically verified healing skin care products [2].

FMI’s report includes a detailed analysis of growth in the Europe region, along with a country-wise assessment that includes Germany, France, Italy, Spain, and the UK. Readers can also find regional trends, regulations, and market growth based on different segments and countries in Europe.

Latin America Mattifying Agents Market Analysis

Latin America is asserting itself as a resilient "Masstige" powerhouse, where economic volatility fails to dampen the demand for personal care. The region functions as a critical volume stabilizer for global brands, who are increasingly localizing production to serve the "tropical oily skin" phenotype. The strategy here is "accessible efficacy", delivering active ingredients at mass-market price points.

• Brazil: Opportunities are expected to rise at a 5.9% CAGR through 2036. The market's resilience is highlighted by strategic corporate commitments, such as ISDIN's public goal to double its sales in Brazil by 2028, confirming the country's status as a high-priority growth pillar for sun and sebum control portfolios [9].

FMI’s report includes a detailed analysis of growth in the Latin America region, along with a country-wise assessment that includes Brazil, Mexico, Argentina, and Chile. Readers can also find regional trends, regulations, and market growth based on different segments and countries in Latin America.

Competitive Aligners for Market Players

The competitive landscape is being redefined by "Supply Chain Sovereignty." In an era of geopolitical fragmentation, the ability to manufacture locally is no longer a cost-saving measure but a survival strategy. Market leaders are those who are aggressively backward-integrating to secure their access to critical raw materials and reduce lead times for high-growth markets.

A prime example of this strategic alignment is Croda International, which has heavily invested in expanding its manufacturing footprint in Asia, including the commissioning of a new surfactants plant in Dahej, India [10]. This move allows the company to service the exploding regional demand for personal care ingredients with local speed and tariff immunity, creating a formidable defensive moat against importers who are reliant on long, vulnerable supply chains. Similarly, Shiseido established the "Shiseido Beauty Park" in early 2025 to centralize consumer co-creation and R&D, moving away from isolated lab work to an integrated innovation model that speeds up time-to-market.

Recent Developments:

The report includes full coverage of key trends from competitive benchmarking. Some of the recent developments covered in the reports:

• In January 2025, Foxtale secured USD 30 million in Series B funding to accelerate the rollout of its acne-focused product lines, signaling strong investor confidence in targeted skincare [4].
• In early 2025, Croda International progressed with the commissioning of its new surfactants facility in Dahej, India, to support the region's growing consumer care sector [10].

Key Players in Mattifying Agents Market

• L'Oréal S.A.
• Beiersdorf AG
• Estée Lauder Companies Inc.
• Shiseido Company, Limited
• Unilever PLC
• Johnson & Johnson (Kenvue)
• Croda International Plc
• Foxtale
• Debut
• ISDIN

Scope of the Report

Mattifying Agents Market Analysis by Segments

Form

• Mattifying Creams
• Mattifying Lotions
• Mattifying Gels
• Mattifying Powders

Skin Type

• Oily Skin
• Combination Skin
• Acne-Prone Skin
• Sensitive Skin

Distribution Channel

• Supermarkets & Hypermarkets
• Online Retail
• Specialty Beauty Stores
• Pharmacies & Drug Stores

End User

• Women
• Men
• Unisex Consumers

Region

• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Indonesia
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
• Europe
  • Germany
  • Italy
  • France
  • United Kingdom
  • Spain
  • Benelux
  • Nordics
  • Central & Eastern Europe
  • Rest of Europe
• North America
  • United States
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Turkey
  • Rest of Middle East & Africa

Bibliography

• [1] Kenvue. (2024). Kenvue Reports First Quarter 2024 Results. Kenvue Investor Relations.
• [2] Beiersdorf. (2025). Beiersdorf delivers solid H1 2025: Strong innovation pipeline to drive acceleration in second half of the year (Press release, 6 August 2025). Beiersdorf Newsroom
• [3] L'Oréal Group. (2025). 2024 Annual Results Press Release. L'Oréal Finance.
• [4] Playbook of Beauty. (2025). Beauty Companies Raised Money Q1 2025: Foxtale Series B. Playbook of Beauty.
• [5] FDA. (2024). Updates on Cosmetic Facility Registration and Product Listing (MoCRA). USA Food and Drug Administration.
• [6] Estée Lauder Companies. (2024). Q2 2024 Earnings Call Transcript. Estée Lauder Investor Relations.
• [7] Failory. (2024/2025). Startups: Cosmetics - Debut Funding. Failory / Crunchbase Data.
• [8] NMPA. (2025). Opinions on Deepening Reform and Policy Update Notification. National Medical Products Administration (China).
• [9] IMARC / ISDIN. (2024). Brazil Beauty Personal Care Market Updates: ISDIN Strategic Goals. Industry News.
• [10] Croda International. (2024). Annual Report and Consumer Care Business Review. Croda Investor Relations.

This Report Addresses

• Market intelligence to enable structured strategic decision making across mature and emerging resin economies
• Market size estimation and 10 year revenue forecasts from 2026 to 2036, supported by validated capacity and trade benchmarks
• Growth opportunity mapping across powder, liquid, and solid forms with emphasis on active ingredient transitions
• Segment and regional revenue forecasts covering building and construction, furniture and joinery, agriculture, automotive, and electrical applications
• Competition strategy assessment including integration models, cost survivability positioning, and compliance capability benchmarking
• Product reformulation and emission compliance tracking including the shift from talc/silica to microbiome-friendly and bio-fermented actives
• Regulatory impact analysis covering formaldehyde emission mandates, indoor air quality thresholds, and export driven specification upgrades
• Market report delivery in PDF, Excel, PPT, and interactive dashboard formats for executive and operational use